REPORT ID 687

EMEA (Europe, Middle East and Africa) Hemostats Market Report 2017

Publish Date
01-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the EMEA Hemostats market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Hemostats for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hemostats market competition by top manufacturers/players, with Hemostats sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Ethicon
    Pfizer
    Baxter International Inc.
    C. R. Bard
    The Medicines Company
    Anika Therapeutics, Inc.
    Advanced Medical Solutions
    Integra LifeSciences Corporation
    B Braun Melsungen AG
    Gelita Medical GmbH
    Equimedical
    Vascular Solutions, Inc.
    Marine Polymer Technologies, Inc.
    Z-Medica, LLC
    CryoLife, Inc.
    BioCer Entwicklungs-GmbH
    Biom?Up SAS

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Hydrocolloid Sponges
    Gelatin Sponges
    Hemostat Powder
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Ophthalmic
    Urology
    Orthopedics
    Capillary Hemorrhage
    Venous Hemorrhage
    Arterial Hemorrhage
    Gynecology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Hemostats Market Report 2017
1 Hemostats Overview
    1.1 Product Overview and Scope of Hemostats
    1.2 Classification of Hemostats
        1.2.1 EMEA Hemostats Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Hemostats Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Hydrocolloid Sponges
        1.2.4 Gelatin Sponges
        1.2.5 Hemostat Powder
        1.2.6 Others
    1.3 EMEA Hemostats Market by Application/End Users
        1.3.1 EMEA Hemostats Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Ophthalmic
        1.3.3 Urology
        1.3.4 Orthopedics
        1.3.5 Capillary Hemorrhage
        1.3.6 Venous Hemorrhage
        1.3.7 Arterial Hemorrhage
        1.3.8 Gynecology
        1.3.9 Others
    1.4 EMEA Hemostats Market by Region
        1.4.1 EMEA Hemostats Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Hemostats (2012-2022)
        1.5.1 EMEA Hemostats Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Hemostats Revenue and Growth Rate (2012-2022)

2 EMEA Hemostats Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Hemostats Market Competition by Players/Manufacturers
        2.1.1 EMEA Hemostats Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Hemostats Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Hemostats Sale Price by Players (2012-2017)
    2.2 EMEA Hemostats (Volume and Value) by Type/Product Category
        2.2.1 EMEA Hemostats Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Hemostats Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Hemostats Sale Price by Type (2012-2017)
    2.3 EMEA Hemostats (Volume) by Application
    2.4 EMEA Hemostats (Volume and Value) by Region
        2.4.1 EMEA Hemostats Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Hemostats Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Hemostats Sales Price by Region (2012-2017)

3 Europe Hemostats (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Hemostats Sales and Value (2012-2017)
        3.1.1 Europe Hemostats Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Hemostats Revenue and Growth Rate (2012-2017)
    3.2 Europe Hemostats Sales and Market Share by Type
    3.3 Europe Hemostats Sales and Market Share by Application
    3.4 Europe Hemostats Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Hemostats Sales Volume by Countries (2012-2017)
        3.4.2 Europe Hemostats Revenue by Countries (2012-2017)
        3.4.3 Germany Hemostats Sales and Growth Rate (2012-2017)
        3.4.4 France Hemostats Sales and Growth Rate (2012-2017)
        3.4.5 UK Hemostats Sales and Growth Rate (2012-2017)
        3.4.6 Russia Hemostats Sales and Growth Rate (2012-2017)
        3.4.7 Italy Hemostats Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Hemostats Sales and Growth Rate (2012-2017)

4 Middle East Hemostats (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Hemostats Sales and Value (2012-2017)
        4.1.1 Middle East Hemostats Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Hemostats Revenue and Growth Rate (2012-2017)
    4.2 Middle East Hemostats Sales and Market Share by Type
    4.3 Middle East Hemostats Sales and Market Share by Application
    4.4 Middle East Hemostats Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Hemostats Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Hemostats Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Hemostats Sales and Growth Rate (2012-2017)
        4.4.4 Israel Hemostats Sales and Growth Rate (2012-2017)
        4.4.5 UAE Hemostats Sales and Growth Rate (2012-2017)
        4.4.6 Iran Hemostats Sales and Growth Rate (2012-2017)

5 Africa Hemostats (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Hemostats Sales and Value (2012-2017)
        5.1.1 Africa Hemostats Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Hemostats Revenue and Growth Rate (2012-2017)
    5.2 Africa Hemostats Sales and Market Share by Type
    5.3 Africa Hemostats Sales and Market Share by Application
    5.4 Africa Hemostats Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Hemostats Sales Volume by Countries (2012-2017)
        5.4.2 Africa Hemostats Revenue by Countries (2012-2017)
        5.4.3 South Africa Hemostats Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Hemostats Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Hemostats Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Hemostats Sales and Growth Rate (2012-2017)

6 EMEA Hemostats Manufacturers/Players Profiles and Sales Data
    6.1 Ethicon
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hemostats Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Ethicon Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Hemostats Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Baxter International Inc.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Hemostats Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Baxter International Inc. Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 C. R. Bard
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Hemostats Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 C. R. Bard Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 The Medicines Company
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Hemostats Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 The Medicines Company Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Anika Therapeutics, Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Hemostats Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Anika Therapeutics, Inc. Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Advanced Medical Solutions
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Hemostats Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Advanced Medical Solutions Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Integra LifeSciences Corporation
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Hemostats Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 B Braun Melsungen AG
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Hemostats Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 B Braun Melsungen AG Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Gelita Medical GmbH
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Hemostats Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Gelita Medical GmbH Hemostats Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Equimedical
    6.12 Vascular Solutions, Inc.
    6.13 Marine Polymer Technologies, Inc.
    6.14 Z-Medica, LLC
    6.15 CryoLife, Inc.
    6.16 BioCer Entwicklungs-GmbH
    6.17 Biom?Up SAS

7 Hemostats Manufacturing Cost Analysis
    7.1 Hemostats Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hemostats

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hemostats Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hemostats Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Hemostats Market Forecast (2017-2022)
    11.1 EMEA Hemostats Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Hemostats Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Hemostats Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Hemostats Price and Trend Forecast (2017-2022)
    11.2 EMEA Hemostats Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Hemostats Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Hemostats Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Hemostats Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Hemostats Sales Forecast by Type (2017-2022)
    11.7 EMEA Hemostats Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer